Dr. Goldlust is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4401 Wornall Road
Kansas City, MO 64111- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 2009 - 2011
- NYU Grossman School of MedicineResidency, Neurology, 2006 - 2009
- Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 2005 - 2006
- Ohio State University College of MedicineClass of 2005
Certifications & Licensure
- KS State Medical License 2023 - 2024
- MO State Medical License 2023 - 2024
- NJ State Medical License 2011 - 2023
- NY State Medical License 2008 - 2011
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Start of enrollment: 2009 Jun 01
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.Prashasti Agrawal, Kevin A David, Zhengming Chen, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin, Samuel Singer, Mary-Kate Malecek, Jordan Carter, Adam Zayac, My...> ;Leukemia & Lymphoma. 2023 May 1
- 1 citationsTumor Treating Fields (TTFields) therapy vs physicians' choice standard-of-care treatment in patients with recurrent glioblastoma: a post-approval registry study (EF-19).Jay-Jiguang Zhu, Samuel A Goldlust, Lawrence R Kleinberg, Jérôme Honnorat, Nancy Ann Oberheim Bush, Zvi Ram> ;Discover. Oncology. 2022 Oct 14
- 8 citationsTetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding TrialSamuel Goldlust, Mojgan Kavoosi, Jennifer Nezzer, Mehran Kavoosi, Walter Korz, Kenneth Deck> ;Toxins. 2021 Mar 25
- Join now to see all
Press Mentions
- Investor Event Turns Spotlight on Novel Brain Cancer Drug Candidate Global Trial Under Way by CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)May 11th, 2022
- John Theurer Cancer Center Treats First Patient in U.S. With Investigational New Treatment for Brain CancerMarch 28th, 2022
- Hackensack University Medical Center Foundation Celebrates Formal Investiture of Samuel A. Goldlust, M.D.December 4th, 2017
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: